Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for kappa receptor (compound)
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- OMIM - Unspecified immunity deficiency
Most Relevant Literature
- Stereoselective Synthesis and Biological Evaluation of Perhydroquinoxaline-Based κ Receptor Agonists…
- A review of kappa opioid receptor antagonists and their clinical trial landscape.
- Targeting the kappa opioid receptor for analgesia and antitumour effects.
- Limitations and potential of κOR biased agonists for pain and itch management.
- Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptor.
Most Relevant Clinical Trials
- Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
- Kappa Opioid Receptor Imaging in Depression (KOR Depression)
- A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)
- Kappa Opioid Receptor Imaging in Anorexia
- FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Stud…
